E-LIB Suche - Ergebnisse für: Parisio, L

1

P460 The POCER index: application of a novel endoscopic sco..:

Parisio, L ; Del Gaudio, A ; Privitera, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i928-i928 , 2024

Link: https://doi.org/10.1093/..

2

OC.07.9: ENDOSCOPIC BALLOON DILATION ASSOCIATED WITH BIOLOG..:

Lopetuso, L.R. ; Coppola, G. ; Alfieri, N....
Digestive and Liver Disease. 56 (2024) - p. S167 , 2024

Link: https://doi.org/10.1016/..

3

OC.07.8: THE POCER INDEX: APPLICATION OF A NOVEL ENDOSCOPIC..:

Del Gaudio, A. ; Parisio, L. ; Cuccia, G....
Digestive and Liver Disease. 56 (2024) - p. S166-S167 , 2024

Link: https://doi.org/10.1016/..

4

P831 Acute infusion reactions due to different biologic age..:

Colantuono, S ; Caruso, C ; Rumi, G...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1548-i1548 , 2024

Link: https://doi.org/10.1093/..

5

P715 Multiparametric assessment of IBD and SpA-IBD patients..:

Privitera, G ; Parisio, L ; Perniola, S...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1346-i1346 , 2024

Link: https://doi.org/10.1093/..

6

P612 Switching from intravenous to subcutaneous VEDOlizumab..:

Ribaldone, D G ; Parisio, L ; Variola, A...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1185-i1185 , 2024

Link: https://doi.org/10.1093/..

7

P881 Real-life vs trial access to biologic therapy differen..:

DI VINCENZO, F ; Maresca, R ; Mora, V...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1624-i1624 , 2024

Link: https://doi.org/10.1093/..

8

P750 Endoscopic balloon dilation associated with biological..:

Lopetuso, L R ; Coppola, G ; Alfieri, N...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1401-i1402 , 2024

Link: https://doi.org/10.1093/..

9

N04 How to manage the concerns of patients with inflammator..:

Napolitano, D ; Settanni, C R ; Parisio, L...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i1039-i1040 , 2023

Link: https://doi.org/10.1093/..

10

OC.04.3 REAL-LIFE VS TRIAL ACCESS TO BIOLOGIC THERAPY DIFFE..:

Laterza, L. ; Di Vincenzo, F. ; Maresca, R....
Digestive and Liver Disease. 55 (2023) - p. S94 , 2023

Link: https://doi.org/10.1016/..

11

P910 Emerging role of IL-33/ST2 and Gut Microbiota axis in ..:

Lopetuso, L R ; Vetrone, L ; Petito, V...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i1023-i1023 , 2023

Link: https://doi.org/10.1093/..

12

T.06.3 EMERGING ROLE OF IL-33/ST2 AND GUT MICROBIOTA AXIS I..:

Lopetuso, L.R. ; Vetrone, L. ; Petito, V....
Digestive and Liver Disease. 55 (2023) - p. S160 , 2023

Link: https://doi.org/10.1016/..

13

OC.17.4 COMBINATION OF ADVANCED THERAPIES IN PATIENTS WITH ..:

Privitera, G. ; Parisio, L. ; Pugliese, D....
Digestive and Liver Disease. 54 (2022) - p. S113 , 2022

Link: https://doi.org/10.1016/..

14

P403 The role of Organic Cation Transporter (OCTN)-1 in pre..:

Puca, P ; Capobianco, I ; Petito, V...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i396-i396 , 2022

Link: https://doi.org/10.1093/..

15

P491 Infectious risk of vedolizumab compared with other bio..:

Innocenti, T ; Roselli, J ; Lynch, E N...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S476-S476 , 2021

Link: https://doi.org/10.1093/..